Concurrent chemotherapy and radiotherapy for advanced non-small-cell lung cancer / 中华放射肿瘤学杂志

0.05), especially the survival rate of stage ⅢA disease.Conclusions Concurrent chemoradiotherapy seems to be better than the sequential counter part for NSCLC,without 3 increasing the toxicity.